{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:04:47Z","timestamp":1791497087474,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93020D00011"],"award-info":[{"award-number":["75N93020D00011"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201500013I"],"award-info":[{"award-number":["HHSN272201500013I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ijrobp.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T13:25:19Z","timestamp":1684761919000},"page":"705-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule"],"prefix":"10.1016","volume":"117","author":[{"given":"Deborah I.","family":"Bunin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold S.","family":"Javitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Gahagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bakke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan H.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina A.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.05.008_bib0001","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1667\/RADE-22-00148.1","article-title":"Considerations of medical preparedness to assess and treat various populations during a radiation public health emergency","volume":"199","author":"Winters","year":"2023","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0002","series-title":"Radiobiology for the Radiologist","author":"Hall","year":"2011"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exphem.2007.01.006","article-title":"Pathophysiological principles underlying the blood cell concentration responses used to assess the severity of effect after accidental whole-body radiation exposure: An essential basis for an evidence-based clinical triage","volume":"35","author":"Fliedner","year":"2007","journal-title":"Exp Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2023.05.008_bib0004","article-title":"Radiation injury after a nuclear detonation: Medical consequences and the need for scarce resources allocation","volume":"5","author":"DiCarlo","year":"2011","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.7326\/0003-4819-140-12-200406150-00015","article-title":"Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group","volume":"140","author":"Waselenko","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0006","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1093\/jrr\/rry004","article-title":"Medical management of acute radiation syndrome and associated infections in a high-casualty incident","volume":"59","author":"Dainiak","year":"2018","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/14656566.2019.1702968","article-title":"Pharmacological management of ionizing radiation injuries: Current and prospective agents and targeted organ systems","volume":"21","author":"Singh","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0008","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1667\/RR15138.1","article-title":"Challenges and benefits of repurposing licensed\/approved\/cleared products for a radiation indication","volume":"190","author":"Price","year":"2018","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0009","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1667\/RR15137.1","article-title":"Challenges and benefits of repurposing products for use during a radiation public health emergency: Lessons learned from biological threats and other disease treatments","volume":"190","author":"DiCarlo","year":"2018","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.624844","article-title":"Repurposing pharmaceuticals previously approved by regulatory agencies to medically counter injuries arising either early or late following radiation exposure","volume":"12","author":"Singh","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0011","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.xphs.2018.09.010","article-title":"Drug repurposing for ebola virus disease: Principles of consideration and the Animal Rule","volume":"108","author":"Bai","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0012","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1038\/npjvaccines.2016.13","article-title":"First vaccine approval under the FDA Animal Rule","volume":"1","author":"Beasley","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2019.06.005","article-title":"The development and approval of tecoviromat (TPOXX), the first antiviral against smallpox","volume":"168","author":"Merchlinsky","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0014","unstructured":"NEUPOGEN (filgrastim) [product monograph]. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/103353s5197lbl.pdf. Accessed April 19, 2023."},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0015","unstructured":"NEULASTA (pegfilgrastim) [product monograph]. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125031s198lbl.pdf. Accessed April 19, 2023."},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0016","unstructured":"LEUKINE (sargramostim) [product monograph]. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/103362s5240lbl.pdf. Accessed April 19, 2023"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0017","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/HP.0000000000000350","article-title":"The effect of radiation dose and variation in neupogen initiation schedule on the mitigation of myelosuppression during the concomitant GI-ARS and H-ARS in a nonhuman primate model of high-dose exposure with marrow sparing","volume":"109","author":"MacVittie","year":"2015","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0018","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1667\/RR13940.1","article-title":"Pegfilgrastim improves survival of lethally irradiated nonhuman primates","volume":"183","author":"Hankey","year":"2015","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0019","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1667\/RR2900.1","article-title":"Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques","volume":"178","author":"Farese","year":"2012","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0020","first-page":"191","article-title":"Sargramostim (rhu GM-CSF) improves survival of non-human primates with severe bone marrow suppression after acute, high-dose, whole-body irradiation","volume":"195","author":"Clayton","year":"2021","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0022","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.intimp.2006.12.005","article-title":"5-Androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression","volume":"7","author":"Stickney","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0023","unstructured":"NPLATE (romiplostim) [product monograph]. Available at:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/125268s172lbl.pdf. Accessed April 19, 2023"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0024","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clpt.2004.08.010","article-title":"Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand","volume":"76","author":"Wang","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0025","first-page":"177","article-title":"[Mpl ligand (thrombopoietin) and platelet regulation]","volume":"54","author":"Wendling","year":"1996","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0026","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09537109777186","article-title":"Biology of thrombopoiesis and the role of Mpl ligand in the production and function of platelets","volume":"8","author":"Sheridan","year":"1997","journal-title":"Platelets"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0027","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2147\/DDDT.S299591","article-title":"A review of romiplostim mechanism of action and clinical applicability","volume":"15","author":"Bussel","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09553002.2019.1625488","article-title":"Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates","volume":"96","author":"Wong","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09553002.2019.1605465","article-title":"Romiplostim (Nplate) as an effective radiation countermeasure to improve survival and platelet recovery in mice","volume":"96","author":"Bunin","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09553002.2021.1844335","article-title":"Total body irradiation models in NHPs - consideration of animal sex and provision of supportive care to advance model development","volume":"97","author":"Beach","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib43","series-title":"OECD Series on Principles of Good Laboratory Practice Compliance Monitoring, ENV\/MC\/CHEM(98)17","year":"1998"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0031","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/HP.0b013e31825f75a7","article-title":"A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management","volume":"103","author":"Farese","year":"2012","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0032","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/HP.0000000000000348","article-title":"Lymphoid and myeloid recovery in rhesus macaques following total body x-irradiation","volume":"109","author":"Farese","year":"2015","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0033","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2003.05.001","article-title":"AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl","volume":"25","author":"Broudy","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0034","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1389201016666150826125331","article-title":"Mitigative effects of a combination of multiple pharmaceutical drugs on the survival of mice exposed to lethal ionizing radiation","volume":"17","author":"Hirouchi","year":"2015","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0035","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1038\/s41598-018-29013-5","article-title":"The thrombopoietin mimetic romiplostim leads to the complete rescue of mice exposed to lethal ionizing radiation","volume":"8","author":"Yamaguchi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0036","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2019.03.023","article-title":"Diverse functions of the thrombopoietin receptor agonist romiplostim rescue individuals exposed to lethal radiation","volume":"136","author":"Yamaguchi","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0037","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1182\/blood.V79.9.2267.2267","article-title":"A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy","volume":"79","author":"Meisenberg","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0038","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1182\/blood.V90.7.2565","article-title":"The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte\/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys","volume":"90","author":"Neelis","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0039","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood.V87.10.4129.bloodjournal87104129","article-title":"Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor","volume":"87","author":"MacVittie","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/cpt.2263","article-title":"Nested case-control study utilizing MID-NET on thrombocytopenia associated with pegfilgrastim in patients treated with antineoplastic agents","volume":"110","author":"Kajiyama","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210663","article-title":"Late effects of total body irradiation on hematopoietic recovery and immune function in rhesus macaques","volume":"14","author":"Hale","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2023.05.008_bib0042","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13566-015-0201-z","article-title":"Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure","volume":"5","author":"DiCarlo","year":"2016","journal-title":"J Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623004492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623004492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:09:37Z","timestamp":1759745377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623004492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0360301623004492"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}